Kestra Medical Technologies, Ltd. (KMTS)

Revenue by Segment

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023
Medical Products	59.82M	27.81M	7.63M
Medical Products Growth	115.05%	264.53%	-
Total	59.82M	27.81M	7.63M
Total Growth	115.05%	264.53%	-

Revenue by Geography

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023
United States	59.82M	27.81M	7.63M
United States Growth	115.05%	264.53%	-
Total	59.82M	27.81M	7.63M
Total Growth	115.05%	264.53%	-

Source: S&P Global Market Intelligence.